Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
ACS Medicinal Chemistry Letters
|
January 25, 2021
Structural Basis for Targeting the Folded P-Loop Conformation of c-MET
Gavin W Collie, Iacovos N Michaelides, Kevin Embrey, et al.
Frontiers in Molecular Neuroscience
|
March 15, 2017
Discovery of Compounds that Positively Modulate the High Affinity Choline Transporter
Parul Choudhary, Emma J Armstrong, Csilla C Jorgensen, et al.
Journal of Medicinal Chemistry
|
November 6, 2012
Ion channels as therapeutic targets: a drug discovery perspective
Sharan K Bagal, Alan D Brown, Peter J Cox, et al.
ACS Medicinal Chemistry Letters
|
March 28, 2015
Design, Synthesis, and Evaluation of Tetrasubstituted Pyridines as Potent 5-HT2C Receptor Agonists
Guy Rouquet, Dianna E Moore, Malcolm Spain, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
January 22, 2025
Development of compounds for targeted degradation of mammalian cryptochrome proteins
Jack Munns, Andrew D Beale, Iacovos N Michaelides, et al.
Journal of the American Chemical Society
|
July 30, 2025
Modular Synthetic Platform for the Elaboration of Fragments in Three Dimensions for Fragment-Based Drug Discovery
Andres R Gomez-Angel, Hanna F Klein, Stephen Y Yao, et al.
ACS Medicinal Chemistry Letters
|
February 19, 2021
Fragment-Based Discovery of Novel Allosteric MEK1 Binders
Paolo Di Fruscia, Fredrik Edfeldt, Igor Shamovsky, et al.
RSC Medicinal Chemistry
|
November 3, 2022
Fragment screening at AstraZeneca: developing the next generation biophysics fragment set
Simon C C Lucas, Ulf Börjesson, Mark J Bostock, et al.
ACS Medicinal Chemistry Letters
|
June 18, 2025
Discovery of Pyrimidoindolones as Novel Family VIII Bromodomain Binders
Jeffrey A Boerth, Marianne Schimpl, Simon C C Lucas, et al.
Journal of Medicinal Chemistry
|
December 17, 2016
Design and Synthesis of a Pan-Janus Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin
Peter Jones, R Ian Storer, Yogesh A Sabnis, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
ACS Medicinal Chemistry Letters
|
January 25, 2021
Structural Basis for Targeting the Folded P-Loop Conformation of c-MET
Gavin W Collie, Iacovos N Michaelides, Kevin Embrey, et al.
Frontiers in Molecular Neuroscience
|
March 15, 2017
Discovery of Compounds that Positively Modulate the High Affinity Choline Transporter
Parul Choudhary, Emma J Armstrong, Csilla C Jorgensen, et al.
Journal of Medicinal Chemistry
|
November 6, 2012
Ion channels as therapeutic targets: a drug discovery perspective
Sharan K Bagal, Alan D Brown, Peter J Cox, et al.
ACS Medicinal Chemistry Letters
|
March 28, 2015
Design, Synthesis, and Evaluation of Tetrasubstituted Pyridines as Potent 5-HT2C Receptor Agonists
Guy Rouquet, Dianna E Moore, Malcolm Spain, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
January 22, 2025
Development of compounds for targeted degradation of mammalian cryptochrome proteins
Jack Munns, Andrew D Beale, Iacovos N Michaelides, et al.
Journal of the American Chemical Society
|
July 30, 2025
Modular Synthetic Platform for the Elaboration of Fragments in Three Dimensions for Fragment-Based Drug Discovery
Andres R Gomez-Angel, Hanna F Klein, Stephen Y Yao, et al.
ACS Medicinal Chemistry Letters
|
February 19, 2021
Fragment-Based Discovery of Novel Allosteric MEK1 Binders
Paolo Di Fruscia, Fredrik Edfeldt, Igor Shamovsky, et al.
RSC Medicinal Chemistry
|
November 3, 2022
Fragment screening at AstraZeneca: developing the next generation biophysics fragment set
Simon C C Lucas, Ulf Börjesson, Mark J Bostock, et al.
ACS Medicinal Chemistry Letters
|
June 18, 2025
Discovery of Pyrimidoindolones as Novel Family VIII Bromodomain Binders
Jeffrey A Boerth, Marianne Schimpl, Simon C C Lucas, et al.
Journal of Medicinal Chemistry
|
December 17, 2016
Design and Synthesis of a Pan-Janus Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin
Peter Jones, R Ian Storer, Yogesh A Sabnis, et al.
Page
of 5